A phase I/II study of αGalactosylceramide-pulsed dendritic cells in patients with advanced or recurrent non-small cell lung cancer No significant financial relationships to disclose. This is an ASCO ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback